BA1302

· Shandong Boan Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BA1302, covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors [Phase 1]